These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Unusual presentation of sarcoid-like reaction on bone marrow level associated with mediastinal lymphadenopathy on (18)F-FDG-PET/CT resembling an early recurrence of Hodgkin's Lymphoma. Fallanca F; Picchio M; Crivellaro C; Mapelli P; Samanes Gajate AM; Sabattini E; Gianolli L; Messa C Rev Esp Med Nucl Imagen Mol; 2012; 31(4):207-9. PubMed ID: 22980128 [TBL] [Abstract][Full Text] [Related]
3. [Resistance to first line chemotherapy treatment in a patient diagnosed of nodular lymphocyte-predominant Hodgkin's lymphoma identified by 18F-FDG PET/CT: diagnostic and therapeutic implications]. Banzo J; Ubieto MA; Giraldo P; Razola P; Prats E; Tardin L; Santapau A; Parra A; Rambalde EF; Velilla J Rev Esp Med Nucl Imagen Mol; 2012; 31(2):89-92. PubMed ID: 21620527 [TBL] [Abstract][Full Text] [Related]
4. Role of FDG-PET in the implementation of involved-node radiation therapy for Hodgkin lymphoma patients. Girinsky T; Aupérin A; Ribrag V; Elleuch M; Fermé C; Bonniaud G; Ruelle C; Alberini JL; Celebic A; Edeline V Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1047-1052. PubMed ID: 25035208 [TBL] [Abstract][Full Text] [Related]
5. Bilateral primary renal lymphoma in a pediatric patient: staging and response evaluation with ¹⁸F-FDG PET/CT. Dhull VS; Mukherjee A; Karunanithi S; Durgapal P; Bal C; Kumar R Rev Esp Med Nucl Imagen Mol; 2015; 34(1):49-52. PubMed ID: 25065972 [TBL] [Abstract][Full Text] [Related]
6. Chemotherapy Response Assessment by FDG-PET-CT in Early-stage Classical Hodgkin Lymphoma: Moving Beyond the Five-Point Deauville Score. Milgrom SA; Dong W; Akhtari M; Smith GL; Pinnix CC; Mawlawi O; Rohren E; Garg N; Chuang H; Yehia ZA; Reddy JP; Gunther JR; Khoury JD; Suki T; Osborne EM; Oki Y; Fanale M; Dabaja BS Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):333-338. PubMed ID: 28068241 [TBL] [Abstract][Full Text] [Related]
7. Whole-body diffusion-weighted MR and FDG-PET/CT in Hodgkin Lymphoma: Predictive role before treatment and early assessment after two courses of ABVD. Albano D; Patti C; Matranga D; Lagalla R; Midiri M; Galia M Eur J Radiol; 2018 Jun; 103():90-98. PubMed ID: 29803392 [TBL] [Abstract][Full Text] [Related]
8. Very low utility of surveillance imaging in early-stage classic Hodgkin lymphoma treated with a combination of doxorubicin, bleomycin, vinblastine, and dacarbazine and radiation therapy. Gandikota N; Hartridge-Lambert S; Migliacci JC; Yahalom J; Portlock CS; Schöder H Cancer; 2015 Jun; 121(12):1985-92. PubMed ID: 25739719 [TBL] [Abstract][Full Text] [Related]
9. Post-ABVD/pre-radiotherapy (18)F-FDG-PET provides additional prognostic information for early-stage Hodgkin lymphoma: a retrospective analysis on 165 patients. Ciammella P; Filippi AR; Simontacchi G; Buglione M; Botto B; Mangoni M; Iotti C; Merli F; Marcheselli L; Bisi G; Ricardi U; Versari A Br J Radiol; 2016; 89(1061):20150983. PubMed ID: 27022777 [TBL] [Abstract][Full Text] [Related]
10. Coregistration of prechemotherapy PET-CT for planning pediatric Hodgkin's disease radiotherapy significantly diminishes interobserver variability of clinical target volume definition. Metwally H; Courbon F; David I; Filleron T; Blouet A; Rives M; Izar F; Zerdoud S; Plat G; Vial J; Robert A; Laprie A Int J Radiat Oncol Biol Phys; 2011 Jul; 80(3):793-9. PubMed ID: 20615626 [TBL] [Abstract][Full Text] [Related]
11. Unusual ¹⁸F-FDG PET/CT finding of an oxyphil parathyroid adenoma in a patient with Hodgkin's Lymphoma. Niccoli-Asabella A; Ferrari C; Antonica F; Scardapane A; Rubini D; Rubini G Rev Esp Med Nucl Imagen Mol; 2014; 33(6):370-3. PubMed ID: 24618092 [TBL] [Abstract][Full Text] [Related]
12. In vivo treatment sensitivity testing with positron emission tomography/computed tomography after one cycle of chemotherapy for Hodgkin lymphoma. Hutchings M; Kostakoglu L; Zaucha JM; Malkowski B; Biggi A; Danielewicz I; Loft A; Specht L; Lamonica D; Czuczman MS; Nanni C; Zinzani PL; Diehl L; Stern R; Coleman M J Clin Oncol; 2014 Sep; 32(25):2705-11. PubMed ID: 25071108 [TBL] [Abstract][Full Text] [Related]
14. [Application of 18F-FDG PET for the assessment of early response to the treatment and prognosis of patients]. Oriuchi N; Higuchi T; Endo K; Tsukamoto N; Matsuda H; Kuji I; Murakami K; Nakajima K Kaku Igaku; 2009 Jun; 46(2):96-9. PubMed ID: 19637820 [TBL] [Abstract][Full Text] [Related]
15. Interim PET After Two ABVD Cycles in Early-Stage Hodgkin Lymphoma: Outcomes Following the Continuation of Chemotherapy Plus Radiotherapy. Simontacchi G; Filippi AR; Ciammella P; Buglione M; Saieva C; Magrini SM; Livi L; Iotti C; Botto B; Vaggelli L; Re A; Merli F; Ricardi U Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):1077-1083. PubMed ID: 26031367 [TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted MRI compared to FDG PET/CT for assessment of early treatment response in lymphoma. Hagtvedt T; Seierstad T; Lund KV; Løndalen AM; Bogsrud TV; Smith HJ; Geier OM; Holte H; Aaløkken TM Acta Radiol; 2015 Feb; 56(2):152-8. PubMed ID: 24585944 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Importance of Bone Marrow Uptake on Baseline Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313 [TBL] [Abstract][Full Text] [Related]
18. [Sarcoidosis-like reaction after treatment with doxorubicin, bleomycin, vinblastine and dacarbazine in a patient with Hodgkin's lymphoma]. Torrent A; Navarro JT; Andreo FC; Ribera JM Med Clin (Barc); 2013 Aug; 141(3):134-5. PubMed ID: 23332624 [No Abstract] [Full Text] [Related]
19. Hodkgin lymphoma concomitant of tuberculosis, a therapeutic challenge for multidisciplinary management. Boilève A; Kuhnowski F; Cassou-Mounat T; Jehanno N; Kirova Y Cancer Radiother; 2020 Jul; 24(4):335-339. PubMed ID: 32444284 [TBL] [Abstract][Full Text] [Related]
20. Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma. Kobe C; Kuhnert G; Kahraman D; Haverkamp H; Eich HT; Franke M; Persigehl T; Klutmann S; Amthauer H; Bockisch A; Kluge R; Wolf HH; Maintz D; Fuchs M; Borchmann P; Diehl V; Drzezga A; Engert A; Dietlein M J Clin Oncol; 2014 Jun; 32(17):1776-81. PubMed ID: 24799482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]